Abstract |
The purpose of this study was to evaluate the initiating activity of the hepatocarcinogen beta-blocker DL-1-(2-nitro-3-methyl-phenoxy)-3-tert-butylamino-propan-2-ol (DL-ZAMI 1305) by the initiation-promotion protocol of Pereira. Female Wistar rats were given a single dose 150 mg/kg of body weight of DL-ZAMI 1305 by gavage 24 hours before or 24 hours after partial hepatectomy. One week later rats were given phenobarbital (0.05%) in the diet for a period of 7 weeks. DL-ZAMI 1305-treatment resulted in the appearance of gamma-glutamyltranspeptidase foci and of other preneoplastic lesions in all animals. Preneoplastic lesions were also present in a fraction of DL-ZAMI 1305-treated animals not subjected to partial hepatectomy, whether given or not phenobarbital. Results obtained in a separate experiment demonstrated that DL-ZAMI 1305-treatment inhibits cell proliferation and induces DNA damage in the regenerating rat liver. The results of this study clearly demonstrated that the beta-blocker DL-ZAMI 1305 is an initiating carcinogen for the liver of female Wistar rats.
|
Authors | N Pacces, M Braga, T Zavanella, M Presta, G Ragnotti |
Journal | Toxicologic pathology
(Toxicol Pathol)
Vol. 14
Issue 4
Pg. 470-6
( 1986)
ISSN: 0192-6233 [Print] United States |
PMID | 2880384
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Adrenergic beta-Antagonists
- Propanolamines
- ZAMI 1305
- DNA
- gamma-Glutamyltransferase
|
Topics |
- Adrenergic beta-Antagonists
(toxicity)
- Animals
- Cell Transformation, Neoplastic
(drug effects)
- DNA
(drug effects)
- Female
- Liver
(drug effects, pathology)
- Liver Regeneration
- Precancerous Conditions
(chemically induced)
- Propanolamines
(toxicity)
- Rats
- Rats, Inbred Strains
- gamma-Glutamyltransferase
(metabolism)
|